Del Nido cardioplegia versus other contemporary solutions for myocardial protection – a literature review [PDF]
European Journal of Translational and Clinical Medicine, 2023 Myocardial protection is one of the most important factors ensuring patient safety during cardiac surgery with the application of cardiopulmonary bypass.
Barbara Brzeska +5 more
doaj +1 more source
Response by Authors to the Letter Regarding Article "Lidocaine and Pinacidil Added to Blood Versus Crystalloid Cardioplegic Solutions: Study in Isolated Hearts" [PDF]
Brazilian Journal of Cardiovascular Surgery, 2019 Helison Pereira do Carmo
doaj +2 more sources
A Cardioplegic Solution with an Understanding of a Cardiochannelopathy [PDF]
Antioxidants, 2021 Cardiac surgeries have been improved by accompanying developing cardioplegia solutions. However, the cardioplegia application presents an ongoing challenge with a view of a sufficiently restored cardiac function. In this review, we focus on the cardioplegia-induced mechanism and summarize the findings of studies undertaken to improve cardioprotective ...
Min Jeong Ji, Jeong Hee Hong
openaire +4 more sources
Effect of single-dose crystalloid cardioplegic agent compared to bloody cardioplegic agent in cardiac surgery in children with Tetralogy of Fallot [PDF]
ARYA Atherosclerosis, 2020 BACKGROUND: Cardioplegia is one of the main post-operative cardiac protective factors widely used in recent decades in the form of crystalloid (St. Thomas) and bloody solutions [del Nido (DN)].
Hamid Bigdelian, Alireza Hosseini
doaj +1 more source
Oxygenation of cardioplegic solutions
Journal of Thoracic and Cardiovascular Surgery, 1987 Gillian A Geffin +2 more
exaly +2 more sources
Antioxidants, 2023 Open-heart surgery is often an unavoidable option for the treatment of cardiovascular disease and prevention of cardiomyopathy. Cardiopulmonary bypass surgery requires manipulating cardiac contractile function via the perfusion of a cardioplegic solution.
Hongting Diao, Haiwei Gu, Qin M. Chen
doaj +1 more source
BMJ Open, 2021 Introduction Myocardial protection is essential for successful cardiac surgery, and the search for an ideal cardioplegic solution has continued since its beginning.
Adriana Silveira Almeida +9 more
doaj +1 more source
Comparison of Custodiol® and modified St. Thomas cardioplegia for myocardial protection in coronary artery bypass grafting [PDF]
Vojnosanitetski Pregled, 2020 Background/Aim. Custodiol® is a hyperpolarizing cardioplegic solution which has been used in our national cardiac surgical practice exclusively for the heart transplant surgery.
Cvetković Dragan +12 more
doaj +1 more source
Custodiol versus Blood Cardioplegia: Comparison of Myocardial Immunohistochemical Analysis and Clinical Outcomes [PDF]
Brazilian Journal of Cardiovascular Surgery, 2022 Introduction: Custodiol (histidine-tryptophan-ketoglutarate) and repetitive blood cardioplegia are the solutions for myocardial protection and cardiac arrest. In this study, we aimed to compare immunohistochemical analysis, clinical outcomes, and cardiac
Onur Sen +8 more
doaj +1 more source
Custodial Cardioplegia and Cardiac Preservation during pediatric Cardiac Surgery Procedures: A Narrative Review [PDF]
Reviews in Clinical Medicine, 2019 Controlled intraoperative cardioplegia is indispensable to pediatric cardiac surgery procedures. Several preservation techniques have been proposed for such purposes, with varying application by different surgeons.
Javad Ramezani +6 more
doaj +1 more source